Clinical Trial Update: Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update indicating that supplementation with Korean Red Ginseng lowered blood pressure and altered circulating biomarkers in prehypertensive subjec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prehypertension

Drugs mentioned

• Korean Red Ginseng (Panax ginseng)

Snippet

Sponsor: Yonsei University | Conditions: Prehypertension | Phase 3 | Status: COMPLETED